BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33436794)

  • 21. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
    J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
    Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
    Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma.
    Ng KY; Chan LH; Chai S; Tong M; Guan XY; Lee NP; Yuan Y; Xie D; Lee TK; Dusetti NJ; Carrier A; Ma S
    Cancer Res; 2017 Sep; 77(17):4602-4612. PubMed ID: 28674078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.
    Lu D; Han C; Wu T
    Oncogene; 2012 Feb; 31(7):842-57. PubMed ID: 21743491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
    Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.
    Marcq I; Nyga R; Cartier F; Amrathlal RS; Ossart C; Ouled-Haddou H; Ghamlouch H; Galmiche A; Chatelain D; Lamotte L; Debuysscher V; Fuentes V; Nguyen-Khac E; Regimbeau JM; Marolleau JP; Latour S; Bouhlal H
    PLoS One; 2013; 8(12):e82918. PubMed ID: 24376606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
    Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
    Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IMB-6G, a novel N-substituted sophoridinic acid derivative, induces endoplasmic reticulum stress-mediated apoptosis via activation of IRE1α and PERK signaling.
    Zhang N; Bi C; Liu L; Dou Y; Tang S; Pang W; Deng H; Song D
    Oncotarget; 2016 Apr; 7(17):23860-73. PubMed ID: 27009865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
    Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
    Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32649753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
    Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
    Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32648918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP.
    Chen Y; Liu JM; Xiong XX; Qiu XY; Pan F; Liu D; Lan SJ; Jin S; Yu SB; Chen XQ
    Oncotarget; 2015 Mar; 6(8):6406-21. PubMed ID: 25788268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma.
    Li S; Peng F; Ning Y; Jiang P; Peng J; Ding X; Zhang J; Jiang T; Xiang S
    J Cell Biochem; 2020 Mar; 121(3):2543-2558. PubMed ID: 31696971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pigment epithelium-derived factor promotes tumor metastasis through an interaction with laminin receptor in hepatocellular carcinomas.
    Hou J; Ge C; Cui M; Liu T; Liu X; Tian H; Zhao F; Chen T; Cui Y; Yao M; Li J; Li H
    Cell Death Dis; 2017 Aug; 8(8):e2969. PubMed ID: 28771223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
    Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
    Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
    Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Columbamine suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK1/2 MAPK signaling pathways.
    Lin Z; Li S; Guo P; Wang L; Zheng L; Yan Z; Chen X; Cheng Z; Yan H; Zheng C; Zhao C
    Life Sci; 2019 Feb; 218():197-204. PubMed ID: 30582951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.